Ocular Drug Delivery and Tissue Repair Strategies
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 107
Special Issue Editors
Interests: ophthalmic drug delivery and formulation of ocular drugs; ocular pharmacokinetics and pharmacodynamics; formulation and stability studies; compounding and compounded formulations; drug efflux via P-glycoprotein/MDR-1; transporter mediated targeted drug delivery
Special Issue Information
Dear Colleagues,
We are pleased to invite contributions to this Special Issue, titled “Ocular Drug Delivery and Tissue Repair Strategies”. The eye is a highly specialized organ protected by complex anatomical and physiological barriers that significantly limit drug penetration, stability, and sustained bioavailability. These challenges reduce therapeutic efficacy for a broad range of ocular diseases affecting both the anterior and posterior segments. Advancing effective ocular drug delivery strategies is, therefore, essential for improving treatments for ocular surface disorders, inflammatory and neovascular diseases, and retinal and optic nerve pathologies such as age-related macular degeneration, diabetic retinopathy, and glaucoma.
This Special Issue aims to highlight innovative ocular drug delivery strategies that enhance the bioavailability of the drug while promoting tissue repair and regeneration. Emphasis will be placed on antibody and biologically active therapeutics, gene- and cell-based therapies, non/minimally invasive drug delivery systems, controlled and sustained-release systems, nanocarriers and hydrogels, and biomaterial-assisted regenerative approaches.
For this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Novel ocular drug delivery platforms;
- Sustained/controlled release systems for anterior and posterior segment diseases;
- Antibody-based/ biologically active drug delivery;
- Biomaterials and hydrogels for corneal repair and regeneration;
- Non-invasive and minimally invasive delivery systems;
- Drug delivery strategies targeting corneal and retinal tissues;
- Gene and cell therapies for ocular tissue repair;
- Tissue engineering and regenerative medicine approaches in ophthalmology;
- Translational and clinically relevant studies in ocular drug delivery.
We encourage submissions that bridge fundamental formulation science with translational and clinical perspectives to advance ocular drug delivery and tissue repair.
We look forward to receiving your valuable contributions.
Dr. Surajit Dey
Guest Editor
Dr. Remya Ammassam Veettil
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular drug delivery
- controlled drug release
- biomaterials and hydrogels
- targeted delivery
- sustained drug release
- noninvasive drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
